| Literature DB >> 19325785 |
Demberelnyamba Dorjnamjin1, Maamaa Ariunaa1, Young Key Shim1.
Abstract
We report a new one phase method for the synthesis of uniform monodisperse crystalline Ag nanoparticles in aqueous systems that has been developed by using newly synthesized mono and dihydroxylated ionic liquids and cationic surfactants based on 1,3-disubstituted imidazolium cations and halogens anions. The hydroxyl functionalized ionic liquids (HFILs) and hydroxyl functionalized cationic surfactants (HFCSs) also simultaneously acts both as the reductant and protective agent. By changing the carbon chain length, alcohol structure and anion of the 1,3-imidazolium based HFILs and HFCSs the particle size, uniform and dispersibility of nanoparticles in aqueous solvents could be controlled. Transmission electron microscopy (TEM), electron diffraction, UV-Vis and NMR, were used for characterization of HFILs, HFCSs and silver nanoparticles. TEM studies on the solution showed representative spherical silver nanoparticles with average sizes 2-8 nm, particularly 2.2 nm and 4.5 nm in size range and reasonable narrow particle size distributions (SD-standard distribution) 0.2 nm and 0.5 nm respectively. The all metal nanoparticles are single crystals with face centered cubic (fcc) structure. The silver nanoparticles surface of plasmon resonance band (lambda(max)) around 420 nm broadened and little moved to the long wavelength region that indicating the formation of silver nanoparticles dispersion with broad absorption around infrared (IR) region. Silver complexes of these HFILs as well as different silver nanoparticles dispersions have been tested in vitro against several gram positive and gram negative bacteria and fungus. The silver nanoparticles providing environmentally friendly and high antimicrobial activity agents.Entities:
Keywords: Silver nanoparticles; antimicrobial activity; hydroxyl functionalized cationic surfactants; hydroxyl functionalized ionic liquids
Year: 2008 PMID: 19325785 PMCID: PMC2635708 DOI: 10.3390/ijms9050807
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1.Molecular structures of hydroxyl functionalized ILs and surfactants.
Scheme 1.Synthesis of hydroxylated ionic liquids.
The MIC of silver nanoparticles solution stabilized by hydroxyl functionalized cationic surfactants.
| Compound number | Substituents
| Anions | MIC (μg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R1 | R2 | R3 | Tested organisms (bacteria and fungi)
| |||||||
| ES | ST | SA | SAR | BS | CA | |||||
| C14H29 | H | HEt | Br | <4 | <4 | <4 | <4 | <4 | <4 | |
| C14H29 | H | diHPr | Cl | 39 | 39 | 19 | 39 | 19 | 19 | |
| C12H25 | Me | HEt | Cl | 39 | 156 | 156 | 78 | 78 | 78 | |
| C14H29 | Me | HEt | Cl | 78 | 156 | 78 | 39 | 19 | 9 | |
| C16H33 | Me | HEt | Cl | 10 | 10 | 19 | 19 | 10 | 10 | |
| 8 | 8 | 8 | ||||||||
| 8 | 8 | 8 | ||||||||
| 1 | 0.5 | 0.25 | 0.25 | 1 | ||||||
| 16 | 1 | 2 | 1 | 2 | ||||||
BAC: benzalconium chloride;
CPC: cetylpyridinium chloride;
ES: E.coli KCTC1924;
ST: S.typhimurium KCTC1926;
SA:S.aureus 209 KCTC1916;
SAR:S.aureus R209 KCTC1928;
BS:B.subtilis KCTC1914;
CA:C.albicans KCTC1940
GM; Gentamycin;
KM:Kanamycin.Me:CH3;
HEt:Hydroxyethyl=HOCH2CH2;
diHPr:dihydroxypropyl=CH2CH2(OH)CH2(OH).
Figure 2.Electron diffraction (1) and TEM (2) images and histogram of silver nanoparticles stabilized by (C12HEtMeIm, 3a) bar length 20 nm.
Figure 4.TEM high and low magnification images of silver nanoparticles (A1, A2 and B1, B2) stabilized by (C14diHPrImCl, 2a) and (C14HEtImBr, 1a) bar length 200 and 100 nm.
Figure 3.Electron diffraction (1) and TEM (2) images and histogram of silver nanoparticles stabilized by (C16HEtMeImCl, 3c), bar length 10 nm.
Figure 5.UV-Vis absorption spectrum of ionic silver (red line) and typical surface plasmon absorption spectrum of silver nanoparticles stabilized by HFIL: [C12H25HEMIm][Cl] (green line).
1H-NMR chemical shift data for 1-tetradecyl-3-hydroxyethylimidazolium bromide.
| No | Im:H2 | Im:H5 | Im:H4 | CH2O | NCH2 | NCH2 | CH2 | γ | mc | ω |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.03, s | 7.64, d | 7.58, d | 4.27–4.38, m | 3.94–3.95, m | 3.82–3.84, t | 3.66–3.68, t | 1.89–2.07, m | 1.27–1.34, br.s | 0.83–0.86, t |
FAB-MS data.
| 309.04 | 339.04 | 323.2 | 351.2 |
1H-NMR chemical shift data for 1-tetradecyl– 3-(2’,3’-dihydroxy)propylimidazolium chloride.
| No | Im:H2 | Im:H5 | Im:H4 | CH2O | OCH2 | OCH | NCH2 | CH2 | mc | ω |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.02, s | 7.66–7.69, d | 7.03–7.26, d | 4.31–4.48, d | 4.04–4.06, d | 3.92–3.94, m | 3.62–3.75, m | 1.79–1.92, m | 1.31, br. s | 0.89-0.93, t |
1H-NMR chemical shift data for long chain quaternary 1-alkyl-3-hydroxyethyl-2-methylimidazolium chlorides.
| No | Im:H5 | Im:H4 | CH2O | OH | NCH2 | αNCH2 | C2CH3 | βCH2 | γCH2 | mc | ω |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.42 | 7.19 | 4.28 | 4.16 | 3.92 | 3.79 | 2.78 | 2.53 | 1.32 | 1.26 | 0.85 | |
| 7.45 | 7.21 | 4.31 | 4.19 | 3.93 | 3.68 | 2.81 | 2.56 | 1.35 | 1.28 | 0.87 |